The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
Blasts rock Damascus during Macron visit
French court shortens Le Pen's ban from office but orders electronic tag
Israeli strikes kill two people in Gaza, medics say
At least 5 dead in major landslide in India's Wayanad
Trump says there will either be a deal with Iran or US will 'finish the job'
